Hollow microneedles for ocular drug delivery

Microneedles (MNs) are micron-sized needles, typically

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of controlled release 2024-07, Vol.371, p.43-66
Hauptverfasser: Gade, Shilpkala, Glover, Katie, Mishra, Deepakkumar, Sharma, Sanjiv, Guy, Owen, Donnelly, Ryan F., Vora, Lalitkumar K., Thakur, Raghu Raj Singh
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 66
container_issue
container_start_page 43
container_title Journal of controlled release
container_volume 371
creator Gade, Shilpkala
Glover, Katie
Mishra, Deepakkumar
Sharma, Sanjiv
Guy, Owen
Donnelly, Ryan F.
Vora, Lalitkumar K.
Thakur, Raghu Raj Singh
description Microneedles (MNs) are micron-sized needles, typically
doi_str_mv 10.1016/j.jconrel.2024.05.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3054433475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365924002979</els_id><sourcerecordid>3054433475</sourcerecordid><originalsourceid>FETCH-LOGICAL-c360t-71e4bb2b010035d18f5642d6e32b77dc3e80421da914f853fd20720cc54f62e93</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwCaAsWZAwfuWxQqgCilSJDaytxJ6gRE5d7Kaof4-rFrasZnPu3JlDyDWFjALN7_us127l0WYMmMhAZkD5CZnSsuCpqCp5SqaRK1Oey2pCLkLoAUByUZyTCY-Q5JWckruFs9Z9J0OnvVshGoshaZ1PnB5t7RPjx8_EoO226HeX5KytbcCr45yRj-en9_kiXb69vM4fl6nmOWzSgqJoGtYABeDS0LKVuWAmR86aojCaYwmCUVNXVLSl5K1hUDDQWoo2Z1jxGbk97F179zVi2KihCxqtrVfoxqA4SCF4fEVGVB7QeH4IHlu19t1Q-52ioPaiVK-OotRelAKpoqiYuzlWjM2A5i_1ayYCDwcA46PbDr0KusOVRtN51BtlXPdPxQ-bjXrI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3054433475</pqid></control><display><type>article</type><title>Hollow microneedles for ocular drug delivery</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Gade, Shilpkala ; Glover, Katie ; Mishra, Deepakkumar ; Sharma, Sanjiv ; Guy, Owen ; Donnelly, Ryan F. ; Vora, Lalitkumar K. ; Thakur, Raghu Raj Singh</creator><creatorcontrib>Gade, Shilpkala ; Glover, Katie ; Mishra, Deepakkumar ; Sharma, Sanjiv ; Guy, Owen ; Donnelly, Ryan F. ; Vora, Lalitkumar K. ; Thakur, Raghu Raj Singh</creatorcontrib><description>Microneedles (MNs) are micron-sized needles, typically &lt;2 mm in length, arranged either as an array or as single needle. These MNs offer a minimally invasive approach to ocular drug delivery due to their micron size (reducing tissue damage compared to that of hypodermic needles) and overcoming significant barriers in drug administration. While various types of MNs have been extensively researched, significant progress has been made in the use of hollow MNs (HMNs) for ocular drug delivery, specifically through suprachoroidal injections. The suprachoroidal space, situated between the sclera and choroid, has been targeted using optical coherence tomography-guided injections of HMNs for the treatment of uveitis. Unlike other MNs, HMNs can deliver larger volumes of formulations to the eye. This review primarily focuses on the use of HMNs in ocular drug delivery and explores their ocular anatomy and the distribution of formulations following potential HMN administration routes. Additionally, this review focuses on the influence of formulation characteristics (e.g., solution viscosity, particle size), HMN properties (e.g., bore or lumen diameter, MN length), and routes of administration (e.g., periocular transscleral, suprachoroidal, intravitreal) on the ocular distribution of drugs. Overall, this paper highlights the distinctive properties of HMNs, which make them a promising technology for improving drug delivery efficiency, precision, and patient outcomes in the treatment of ocular diseases. [Display omitted]</description><identifier>ISSN: 0168-3659</identifier><identifier>ISSN: 1873-4995</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2024.05.013</identifier><identifier>PMID: 38735395</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Administration, Ophthalmic ; Animals ; Drug Delivery Systems ; Eye - metabolism ; Hollow microneedles ; Humans ; Microinjections - instrumentation ; Microinjections - methods ; Microparticles ; Minimally invasive ; Nanoparticles ; Needles ; Optical coherence tomography ; Periocular ; Pharmaceutical Preparations - administration &amp; dosage ; Suprachoroidal ; Transscleral ; Uveitis ; Vasculature</subject><ispartof>Journal of controlled release, 2024-07, Vol.371, p.43-66</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c360t-71e4bb2b010035d18f5642d6e32b77dc3e80421da914f853fd20720cc54f62e93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168365924002979$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65534</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38735395$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gade, Shilpkala</creatorcontrib><creatorcontrib>Glover, Katie</creatorcontrib><creatorcontrib>Mishra, Deepakkumar</creatorcontrib><creatorcontrib>Sharma, Sanjiv</creatorcontrib><creatorcontrib>Guy, Owen</creatorcontrib><creatorcontrib>Donnelly, Ryan F.</creatorcontrib><creatorcontrib>Vora, Lalitkumar K.</creatorcontrib><creatorcontrib>Thakur, Raghu Raj Singh</creatorcontrib><title>Hollow microneedles for ocular drug delivery</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>Microneedles (MNs) are micron-sized needles, typically &lt;2 mm in length, arranged either as an array or as single needle. These MNs offer a minimally invasive approach to ocular drug delivery due to their micron size (reducing tissue damage compared to that of hypodermic needles) and overcoming significant barriers in drug administration. While various types of MNs have been extensively researched, significant progress has been made in the use of hollow MNs (HMNs) for ocular drug delivery, specifically through suprachoroidal injections. The suprachoroidal space, situated between the sclera and choroid, has been targeted using optical coherence tomography-guided injections of HMNs for the treatment of uveitis. Unlike other MNs, HMNs can deliver larger volumes of formulations to the eye. This review primarily focuses on the use of HMNs in ocular drug delivery and explores their ocular anatomy and the distribution of formulations following potential HMN administration routes. Additionally, this review focuses on the influence of formulation characteristics (e.g., solution viscosity, particle size), HMN properties (e.g., bore or lumen diameter, MN length), and routes of administration (e.g., periocular transscleral, suprachoroidal, intravitreal) on the ocular distribution of drugs. Overall, this paper highlights the distinctive properties of HMNs, which make them a promising technology for improving drug delivery efficiency, precision, and patient outcomes in the treatment of ocular diseases. [Display omitted]</description><subject>Administration, Ophthalmic</subject><subject>Animals</subject><subject>Drug Delivery Systems</subject><subject>Eye - metabolism</subject><subject>Hollow microneedles</subject><subject>Humans</subject><subject>Microinjections - instrumentation</subject><subject>Microinjections - methods</subject><subject>Microparticles</subject><subject>Minimally invasive</subject><subject>Nanoparticles</subject><subject>Needles</subject><subject>Optical coherence tomography</subject><subject>Periocular</subject><subject>Pharmaceutical Preparations - administration &amp; dosage</subject><subject>Suprachoroidal</subject><subject>Transscleral</subject><subject>Uveitis</subject><subject>Vasculature</subject><issn>0168-3659</issn><issn>1873-4995</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EoqXwCaAsWZAwfuWxQqgCilSJDaytxJ6gRE5d7Kaof4-rFrasZnPu3JlDyDWFjALN7_us127l0WYMmMhAZkD5CZnSsuCpqCp5SqaRK1Oey2pCLkLoAUByUZyTCY-Q5JWckruFs9Z9J0OnvVshGoshaZ1PnB5t7RPjx8_EoO226HeX5KytbcCr45yRj-en9_kiXb69vM4fl6nmOWzSgqJoGtYABeDS0LKVuWAmR86aojCaYwmCUVNXVLSl5K1hUDDQWoo2Z1jxGbk97F179zVi2KihCxqtrVfoxqA4SCF4fEVGVB7QeH4IHlu19t1Q-52ioPaiVK-OotRelAKpoqiYuzlWjM2A5i_1ayYCDwcA46PbDr0KusOVRtN51BtlXPdPxQ-bjXrI</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Gade, Shilpkala</creator><creator>Glover, Katie</creator><creator>Mishra, Deepakkumar</creator><creator>Sharma, Sanjiv</creator><creator>Guy, Owen</creator><creator>Donnelly, Ryan F.</creator><creator>Vora, Lalitkumar K.</creator><creator>Thakur, Raghu Raj Singh</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202407</creationdate><title>Hollow microneedles for ocular drug delivery</title><author>Gade, Shilpkala ; Glover, Katie ; Mishra, Deepakkumar ; Sharma, Sanjiv ; Guy, Owen ; Donnelly, Ryan F. ; Vora, Lalitkumar K. ; Thakur, Raghu Raj Singh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c360t-71e4bb2b010035d18f5642d6e32b77dc3e80421da914f853fd20720cc54f62e93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Administration, Ophthalmic</topic><topic>Animals</topic><topic>Drug Delivery Systems</topic><topic>Eye - metabolism</topic><topic>Hollow microneedles</topic><topic>Humans</topic><topic>Microinjections - instrumentation</topic><topic>Microinjections - methods</topic><topic>Microparticles</topic><topic>Minimally invasive</topic><topic>Nanoparticles</topic><topic>Needles</topic><topic>Optical coherence tomography</topic><topic>Periocular</topic><topic>Pharmaceutical Preparations - administration &amp; dosage</topic><topic>Suprachoroidal</topic><topic>Transscleral</topic><topic>Uveitis</topic><topic>Vasculature</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gade, Shilpkala</creatorcontrib><creatorcontrib>Glover, Katie</creatorcontrib><creatorcontrib>Mishra, Deepakkumar</creatorcontrib><creatorcontrib>Sharma, Sanjiv</creatorcontrib><creatorcontrib>Guy, Owen</creatorcontrib><creatorcontrib>Donnelly, Ryan F.</creatorcontrib><creatorcontrib>Vora, Lalitkumar K.</creatorcontrib><creatorcontrib>Thakur, Raghu Raj Singh</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gade, Shilpkala</au><au>Glover, Katie</au><au>Mishra, Deepakkumar</au><au>Sharma, Sanjiv</au><au>Guy, Owen</au><au>Donnelly, Ryan F.</au><au>Vora, Lalitkumar K.</au><au>Thakur, Raghu Raj Singh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hollow microneedles for ocular drug delivery</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2024-07</date><risdate>2024</risdate><volume>371</volume><spage>43</spage><epage>66</epage><pages>43-66</pages><issn>0168-3659</issn><issn>1873-4995</issn><eissn>1873-4995</eissn><abstract>Microneedles (MNs) are micron-sized needles, typically &lt;2 mm in length, arranged either as an array or as single needle. These MNs offer a minimally invasive approach to ocular drug delivery due to their micron size (reducing tissue damage compared to that of hypodermic needles) and overcoming significant barriers in drug administration. While various types of MNs have been extensively researched, significant progress has been made in the use of hollow MNs (HMNs) for ocular drug delivery, specifically through suprachoroidal injections. The suprachoroidal space, situated between the sclera and choroid, has been targeted using optical coherence tomography-guided injections of HMNs for the treatment of uveitis. Unlike other MNs, HMNs can deliver larger volumes of formulations to the eye. This review primarily focuses on the use of HMNs in ocular drug delivery and explores their ocular anatomy and the distribution of formulations following potential HMN administration routes. Additionally, this review focuses on the influence of formulation characteristics (e.g., solution viscosity, particle size), HMN properties (e.g., bore or lumen diameter, MN length), and routes of administration (e.g., periocular transscleral, suprachoroidal, intravitreal) on the ocular distribution of drugs. Overall, this paper highlights the distinctive properties of HMNs, which make them a promising technology for improving drug delivery efficiency, precision, and patient outcomes in the treatment of ocular diseases. [Display omitted]</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>38735395</pmid><doi>10.1016/j.jconrel.2024.05.013</doi><tpages>24</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0168-3659
ispartof Journal of controlled release, 2024-07, Vol.371, p.43-66
issn 0168-3659
1873-4995
1873-4995
language eng
recordid cdi_proquest_miscellaneous_3054433475
source MEDLINE; Elsevier ScienceDirect Journals
subjects Administration, Ophthalmic
Animals
Drug Delivery Systems
Eye - metabolism
Hollow microneedles
Humans
Microinjections - instrumentation
Microinjections - methods
Microparticles
Minimally invasive
Nanoparticles
Needles
Optical coherence tomography
Periocular
Pharmaceutical Preparations - administration & dosage
Suprachoroidal
Transscleral
Uveitis
Vasculature
title Hollow microneedles for ocular drug delivery
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-19T01%3A46%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hollow%20microneedles%20for%20ocular%20drug%20delivery&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Gade,%20Shilpkala&rft.date=2024-07&rft.volume=371&rft.spage=43&rft.epage=66&rft.pages=43-66&rft.issn=0168-3659&rft.eissn=1873-4995&rft_id=info:doi/10.1016/j.jconrel.2024.05.013&rft_dat=%3Cproquest_cross%3E3054433475%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3054433475&rft_id=info:pmid/38735395&rft_els_id=S0168365924002979&rfr_iscdi=true